Evidence map›Paper›PMID 36775890›Full record

ArticlePediatric pulmonology2023

Built environment factors predictive of early rapid lung function decline in cystic fibrosis.

Emrah Gecili, Cole Brokamp, Erika Rasnick, Pedro M Afonso, Eleni-Rosalina Andrinopoulou, Judith W Dexheimer, John P Clancy, Ruth H Keogh, Yizhao Ni, Anushka Palipana and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Pediatric pulmonology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 3 countries.

Emrah GeciliDivision of Biostatistics & Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Cole BrokampDivision of Biostatistics & Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Erika RasnickDivision of Biostatistics & Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Pedro M AfonsoDepartment of Biostatistics, Erasmus Medical Center, Rotterdam, The Netherlands.
Eleni-Rosalina AndrinopoulouDepartment of Biostatistics, Erasmus Medical Center, Rotterdam, The Netherlands.
Judith W DexheimerDivision of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
John P ClancyDepartment of Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA.
Ruth H KeoghLondon School of Hygiene and Tropical Medicine, London, UK.
Yizhao NiDivision of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Anushka PalipanaDivision of Biostatistics & Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.ORCID 0000-0001-5237-1397
Teresa PestianDivision of Biostatistics & Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Andrew VancilDivision of Biostatistics & Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Grace C ZhouDepartment of Mathematics, Division of Statistics and Data Science, University of Cincinnati, Cincinnati, Ohio, USA.
Weiji SuEli Lilly and Company, Indianapolis, Indiana, USA.
Christopher SiracusaDivision of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.ORCID 0000-0001-8681-1725
Patrick RyanDivision of Biostatistics & Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Rhonda D SzczesniakDivision of Biostatistics & Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.ORCID 0000-0003-0705-715X
Cincinnati Children's Hospital Medical Center · USErasmus MC · NLEli Lilly (United States) · USLondon School of Hygiene & Tropical Medicine · GBSt. Jude Children's Research Hospital · US

Funding

Pilot and Feasibility ProgramP30DK117467 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Raouf S. Amin · 2018 to 2026
$11.4M
R01- Mapping environmental contributions to rapid lung disease progression in cystic fibrosisR01HL141286 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI SZCZESNIAK, RHONDA · 2019 to 2023
$2.3M
Medical Research Council MR/S017968/1NHLBI NIH HHS R01 HL141286NIDDK NIH HHS P30 DK117467
6 · The paper itself

Abstract

backgroundThe extent to which environmental exposures and community characteristics of the built environment collectively predict rapid lung function decline, during adolescence and early adulthood in cystic fibrosis (CF), has not been examined.

objectiveTo identify built environment characteristics predictive of rapid CF lung function decline.

methodsWe performed a retrospective, single-center, longitudinal cohort study (n = 173 individuals with CF aged 6-20 years, 2012-2017). We used a stochastic model to predict lung function, measured as forced expiratory volume in 1 s (FEV MEASUREMENTS AND MAIN

resultsThe final model, which included ECAT, material deprivation index, and greenspace, alongside traditional demographic/clinical predictors, significantly improved fit and prediction, compared with only demographic/clinical predictors (Likelihood Ratio Test statistic: 26.78, p < 0.0001; the difference in Akaike Information Criterion: 15). An increase of 0.1 μg/m

conclusionTraffic-related air pollution exposure is an important predictor of rapid pulmonary decline that, coupled with community-level material deprivation and routinely collected demographic/clinical characteristics, enhance CF prognostication and enable personalized environmental health interventions.

Indexed as

Cystic FibrosisAdolescentAdultCohort StudiesForced Expiratory VolumeHumansLongitudinal StudiesLungRetrospective Studiescommunity material deprivationgeomarkergreenspacemedical monitoringtraffic-related air pollution

Identifiers

PMID36775890
PMCPMC10121820
OpenAlexW4320490731

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.